REXAHN PHARMACEUTICALS INC's ticker is REXN and the CUSIP is 761640309. A total of 18 filers reported holding REXAHN PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $55,000 | -26.7% | 26,579 | 0.0% | 0.00% | – |
| Q2 2020 | $75,000 | +59.6% | 26,579 | 0.0% | 0.00% | – |
| Q1 2020 | $47,000 | -53.0% | 26,579 | -50.0% | 0.00% | – |
| Q4 2019 | $100,000 | +85.2% | 53,158 | +100.0% | 0.00% | – |
| Q3 2019 | $54,000 | -60.6% | 26,579 | 0.0% | 0.00% | – |
| Q2 2019 | $137,000 | – | 26,579 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|